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This is an open access artiMultidrug-resistant Gram-negative bacteria (GNB) are
increasingly being reported worldwide. The spread of
carbapenemase-producing Enterobacteriaceae, Pseudomonas and
Acinetobacter species have become a global threat. The emer-
gence of resistance to carbapenems makes the treatment for
infections caused by these carbapenem-resistant strains very
limited [1–3]. Different types of carbapenemases have been
reported, such as Ambler class A Klebsiella pneumoniae carba-
penemase (KPC) and Guiana extended spectrum (GES) β-lac-
tamase, Ambler class B metallo-β-lactamases (MBL) and Ambler
class D oxacillinase type [1].
Rapid methods for detecting carbapenemase producers have
been described, such as the MALDI-TOF MS (matrix-assisted
laser desorption/ionization time-of-ﬂight mass spectrometry)
carbapenemase assay [4]. Previous studies have described a
rapid biochemical carbapenemase detection method based on
imipenem hydrolysis, the Carba NP test, for Enterobacteriaceae
[5] and Pseudomonas species [6], as well as the CarbAcineto NP
test for Acinetobacter species [7]. Recently, however, several
authors have published evaluations of the Carba NP and the
CarbAcineto NP tests; their criticisms focussed essentially on
the absence of detection of oxacillinase (OXA) type carbape-
nemases [8–10].
Here we describe a modiﬁed Carba NP (MCNP) test which
enables the rapid detection of different carbapenemases (KPC,
MBL and OXA types) from Enterobacteriaceae, Pseudomonas and
Acinetobacter species using a single protocol.
One hundred ten previously characterized GNB, including 69
carbapenemase-producing GNB (Enterobacteriaceae n = 14,
Pseudomonas aeruginosa n = 11 and Acinetobacter baumannii
n = 44), and 41 non-carbapenemase-producing GNB, including
Enterobacteriaceae (n = 24), P. aeruginosa (n = 5) and A. baumannii
(n = 12), were tested in two laboratories including Unité de
recherche sur les maladies infectieuses et tropicales émergentes
(URMITE), Aix-Marseille University, Marseille, France, and Mi-
crobial Ecology laboratory, Béjaia University, Béjaia, Algeria
(Table 1). Carbapenemase activity was assessed using phenotypic
and genotypic tests, including the modiﬁed Hodge test, MALDI-
TOF MS assay, PCR ampliﬁcation and sequencing [4,11].
The Carba NP and the CarbAcineto NP tests are straight-
forward biochemical tests which identify carbapenemase pro-
duction in GNB by detecting imipenem hydrolysis using phenol
red solution as a colour indicator and a bacterial lysis buffer (B-
PER II, Bacterial Protein Extraction Reagent) for Enter-
obacteriaceae and Pseudomonas species (Carba NP test) [5,6]
and 5 M NaCl for Acinetobacter species (CarbAcineto NP
test) [7].
In order to use a single protocol to detect the production of
carbapenemases in the three types of bacteriaNew Microbe and New Infect 2015; 7: 89–93
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TABLE 1. Test results for Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii strains
Group Species Carbapenemase or other β-lactamase gene
Test result by:
MHT MALDI-TOF MS MCNP
Enterobacteriaceae Klebsiella pneumoniae H5500M NDM-1 + + +
K. pneumoniae KpnaseyM NDM-1 + + +
K. pneumoniae U2A 2246M KPC-3 + + +
K. pneumoniaeA KPC-3 + + +
K. pneumoniae 360M KPC-2 + + +
K. pneumoniaeM OXA-48 + + +
K. pneumoniae 413A TEM-1/CTX-M-3/SHV-12/DHA-1 − − −
K. pneumoniae 473A TEM-1/CTX-M-15/OXA-1 − − −
K. pneumoniae 463A TEM-1/CTX-M-15 − − −
K. pneumoniae 550A TEM-1/CTX-M-3 − − −
K. pneumoniae 47A TEM-1/CMY-4 − − −
K. pneumoniae 123A TEM-1/CMY-4 − − −
K. pneumoniae 318A CTX-M-15 − − −
K. pneumoniae 476A CTX-M-15 − − −
K. pneumoniae 613A CMY-4 − − −
K. pneumoniae 615A CMY-4 − − −
Escherichia coli H5636M NDM-1 + + +
E. coli 181A NDM-5 + + +
E. coliM NDM-5 + + +
E. coli 99A OXA-48 + + +
E. coli 100A OXA-48 + + +
E. coli 132A OXA-48 + + +
E. coli 192A OXA-48 + + +
E. coliM OXA-48 + + +
E. coli 544A TEM-1/CTX-M-15/OXA-1 − − −
E. coli 469A TEM-1/CTX-M-3/OXA-1 − − −
E. coli 472A TEM-1/CTX-M-3/OXA-1 − − −
E. coli 234A TEM-1/CTX-M-15/CMY-4 − − −
E. coli 611A TEM-1/CTX-M-15/CMY-4 − − −
E. coli 536A TEM-1/CTX-M-15 − − −
E. coli 534A CTX-M-15/OXA-1 − − −
E. coli 542A CTX-M-15/OXA-1 − − −
E. coli 560A TEM-1/CMY-4 − − −
E. coli 606A TEM-1/CMY-4 − − −
E. coli ATCC 25922M — − − −
E. coli 7624M — − − −
E. cloacae 308A TEM-1/CTX-M-15/OXA-1 − − −
E. cloacae 570A TEM-1/CTX-M-15 − − −
Pseudomonas P. aeruginosaM VIM-2 + + +
P. aeruginosaM VIM-2 + + +
P. aeruginosaM VIM-2 + + +
P. aeruginosaM VIM-2 + + +
P. aeruginosaM VIM-2 + + +
P. aeruginosaM VIM-2 + + +
P. aeruginosaM VIM-2 + + +
P. aeruginosaM VIM-2 + + +
P. aeruginosaM VIM-2 + + +
P. aeruginosaM VIM-2 + + +
P. aeruginosaM — − − −
P. aeruginosaM — − − −
P. aeruginosaM — − − −
P. aeruginosaM — − − −
P. aeruginosaM — − − −
P. aeruginosa UAA 2257M IMP-1 + + +
Acinetobacter A. baumanniiA OXA-23 + + +
A. baumanniiA OXA-23 + + +
A. baumanniiA OXA-23 + + +
A. baumanniiA OXA-23 + + +
A. baumanniiA OXA-23 + + +
A. baumanniiA OXA-23 + + +
A. baumanniiM OXA-23 + + +
A. baumanniiM OXA-23 + + +
A. baumanniiM OXA-23 + + +
A. baumanniiM OXA-23 + + +
A. baumanniiM OXA-24 + + +
A. baumanniiM OXA-24 + + +
A. baumanniiM OXA-24 + + +
A. baumanniiM OXA-24 + + +
A. baumanniiM OXA-24 + + +
A. baumanniiM OXA-24 + + +
A. baumanniiA OXA-24 + + +
A. baumanniiA OXA-24 + + +
A. baumanniiA OXA-24 + + +
A. baumanniiA OXA-24 + + +
A. baumanniiM OXA-58 + + +
A. baumanniiM OXA-23/OXA-24 + + +
A. baumanniiA OXA-23/OXA-24 + + +
A. baumanniiA OXA-23/OXA-24 + + +
A. baumanniiA NDM-1 + + +
A. baumanniiA NDM-1 + + +
A. baumanniiA NDM-1 + + +
A. baumanniiA NDM-1 + + +
A. baumanniiA NDM-1 + + +
A. baumanniiM NDM-1 + + +
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TABLE 1. Continued
Group Species Carbapenemase or other β-lactamase gene
Test result by:
MHT MALDI-TOF MS MCNP
A. baumanniiM NDM-1 + + +
A. baumanniiM NDM-1 + + +
A. baumanniiM NDM-1 + + +
A. baumanniiM NDM-1 + + +
A. baumanniiM OXA-23/NDM-1 + + +
A. baumanniiM OXA-23/NDM-1 + + +
A. baumanniiM OXA-23/NDM-1 + + +
A. baumanniiM OXA-23/NDM-1 + + +
A. baumanniiM OXA-23/NDM-1 + + +
A. baumanniiM OXA-23/NDM-1 + + +
A. baumanniiA OXA-23/NDM-1 + + +
A. baumanniiA OXA-23/NDM-1 + + +
A. baumanniiA OXA-23/NDM-1 + + +
A. baumanniiA OXA-23/NDM-1 + + +
A. baumanniiA TEM-128 − − −
A. baumanniiA TEM-128 − − −
A. baumanniiA TEM-128 − − −
A. baumanniiA TEM-128 − − −
A. baumanniiA TEM-128 − − −
A. baumanniiA TEM-128 − − −
A. baumanniiA TEM-128 − − −
A. baumanniiM TEM-128 − − −
A. baumanniiM TEM-128 − − −
A. baumanniiM TEM-128 − − −
A. baumannii AYEM VEB-1 − − −
A. baumannii SDFM — − − −
MALDI-TOF MS, matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry; MCNP, modiﬁed Carba NP test; MHT, modiﬁed Hodge test.
AStrains tested in Microbial Ecology Laboratory, Béjaia University, Béjaia, Algeria.
MStrains tested in Unité de recherche sur les maladies infectieuses et tropicales émergentes (URMITE), Aix-Marseille University, Marseille, France.
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accelerate the speed with which results are produced, the lysis
buffer and pH of the colour indicator solution used in the Carba
NP and CarbAcineto NP tests were changed.
In the MCNP test, the lysis buffers used for the Carba NP
test and CarbAcineto NP test, B-PER II, Bacterial Protein
Extraction Reagent and NaCl 5 M, respectively, were replaced
by cetyl trimethyl ammonium bromide (CTAB) 0.02%, and the
pH value of the phenol red solution was adjusted to 7.5
(instead of 7.8). In addition, two steps used in the previous
protocols [5,6], centrifugation and incubation at room tem-
perature for 30 minutes, were eliminated in our method. TheseFIG. 1. Modiﬁed Carba NP test results for Enterobacteriaceae, Pseudomonas a
positive E. coli. (C) KPC-2-positive Klebsiella pneumoniae 360. (D) IMP-1-positiv
baumannii. (F) OXA-24-positive A. baumannii. (G) NDM-1-positive A. baumann
cetyl trimethyl ammonium bromide (CTAB) 0.02%. (b) Tube containing phen
imipenem and CTAB 0.02%.
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The MCNP test was performed as follows. One inoculation
loop (10 μL) of the tested strain, directly recovered from a
Mueller Hinton agar plate (bioMérieux, Marcy l’Étoile, France),
was resuspended in 200 μL of 0.02% CTAB (Sigma-Aldrich
Chimie, Saint-Quentin-Fallavier, France) and vortexed for 1 to
2 minutes. Subsequently, 100 μL of the bacterial suspension was
mixed with 100 μL of diluted phenol red solution (2 mL of
phenol red (Sigma-Aldrich) solution 0.5% (wt/vol) with 16.6 mL
of distilled water) containing 0.1 mM ZnSO4 (pH 7.5) in the ﬁrst
tube, tube 1, used as negative control, and a diluted phenol rednd Acinetobacter species. (A) Escherichia coli ATCC 25922. (B) NDM-5-
e Pseudomonas aeruginosa UAA 2257. (E) OXA-23-positive Acinetobacter
ii. (a) Tube containing phenol red solution 0.1 mM ZnSO4 (pH 7.5) and
ol red solution 0.1 mM ZnSO4 (pH 7.5) supplemented with 6 mg/mL of
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6 mg/mL of commercially available imipenem (Tienam 500;
Merck Sharp & Dohme, Paris, France) in the second tube, tube
2. Tubes 1 and 2 were vortexed, then incubated at 37°C for a
maximum of 2 hours.
Carbapenemase activity was revealed when the test and
negative control solutions, respectively, were yellow vs. red or
orange vs. red. In contrast, both solutions remained red in the
case of noncarbapenemase producers (Fig. 1).
The results showed that the MCNP method detected all
carbapenemases produced by carbapenem-resistant strains
with 100% sensitivity and 100% speciﬁcity. Positive results were
observed at different times for the different carbapenemases
types (MBL, KPC and OXA-48 at 10 to 30 minutes vs. 1 to 2
hours for OXA type). The most interesting aspect of this
method is that the colour changed from red to orange or
yellow (positive result) even before incubation in some cases
(NDM-5-producing Escherichia coli, NDM-1-producing Klebsiella
pneumoniae (Kpnasey) and imipenem-producing P. aeruginosa
UAA2257). Moreover, a higher inoculums (two inoculation
loops (10 μL)) is recommended for Acinetobacter species tests.TABLE 2. Results of MCNP test applied for carbapenem-resistant s





10/11/2014 Urine Klebsiella pneumoniae R
20/11/2014 Rectal swab Escherichia coli R
25/11/2014 Bronchoalveolar lavage ﬂuid K. pneumoniae R
05/12/2014 Bronchoalveolar lavage ﬂuid K. pneumoniae R
08/12/2014 Rectal swab K. pneumoniae R
09/12/2014 Blood culture K. pneumoniae R
11/12/2014 Urine Enterobacter cloacae R
21/12/2014 Stools K. pneumoniae R
31/12/2014 Spittle K. pneumoniae R
12/01/2015 Urine E. coli R
24/01/2015 Armpit swab K. pneumoniae R
02/02/2015 Rectal swab K. pneumoniae R
06/02/2015 Urine E. coli R
17/02/2015 Urine E. coli R
19/02/2015 Spittle K. pneumoniae R
20/02/2015 Rectal swab K. pneumoniae R
23/02/2015 Urine K. pneumoniae R
04/03/2015 Rectal swab E. cloacae R
04/03/2015 Rectal swab K. pneumoniae R
16/03/2015 Rectal swab K. pneumoniae R
23/03/2015 Bronchial aspirate K. pneumoniae R
30/03/2015 Armpit swab K. pneumoniae R
31/03/2015 Urine K. pneumoniae R
13/04/2015 Sinus Serratia marcescens R
13/04/2015 Blood culture E. cloacae R
18/04/2015 Blood culture E. coli R
18/04/2015 Rectal swab K. pneumoniae R
18/04/2015 Blood culture E. coli R
04/05/2015 Urine K. pneumoniae R
30/04/2015 Urine K. pneumoniae R
07/05/2015 Bronchial aspirate K. pneumoniae R
08/05/2015 Blood culture Acinetobacter baumannii NT
11/05/2015 Urine A. baumannii NT
18/05/2015 Rectal swab K. pneumoniae R
ETP, ertapenem; IMP, imipenem; MCNP, modiﬁed Carba NP test; NT, not tested; R, resista
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Hospital, Marseille, France. It was performed when antibiotic
susceptibility testing revealed a resistance to ertapenem and
susceptibility or resistance to imipenem. The suspicion of car-
bapenemase producers, in particular OXA-48, was based on
this phenotype. Between November 2014 and May 2015, a total
of 233 strains were tested. Among them, 35 positives strains
with carbapenemase producers were detected (Table 2). These
positives strains were isolated from 25 different patients. These
results conﬁrm the efﬁciency of the MCNP test with high
sensitivity, given the detection of all strains producing OXA-48-
type carbapenemases. Also, two carbapenemase-producing A.
baumannii were detected, thus conﬁrming the advantages of the
MCNP test.
In conclusion, the advantages of the MCNP test are the
detection of different carbapenemase types from Enter-
obacteriaceae, Pseudomonas and Acinetobacter species using a
single protocol, as well as the short time to results, particularly
in the case of MBL-producing Enterobacteriaceae and Pseudo-
monas species. In addition, the effectiveness of this test on a







































nt; S, susceptible; I, Intermediate.
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bacterial strain.
Interestingly, as well as using this test in developed countries
such as France (URMITE laboratories, La Timone Hospital),
given the simplicity and the low cost of the MCNP test, it could
be used by any laboratory, including laboratories in developing
countries. In Algeria, this test has been used in the Microbial
Ecology Laboratory of Béjaia University since May 2014, and it
will soon be introduced to laboratories in Algerian hospitals.Conﬂict of interestNone declared.AcknowledgementsWe thank L. Hadjadj, A. Bergal, M. A. El-Gawad El-Sayed and N.
Mathlouthi for their contributions. Supported in part by CNRS
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